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Abstract 
The use of silicone as filler material has been banned by FDA. Nevertheless, there are still some risks 
of using topical silicone, particularly cosmetic products that contain silicone. Bioavailability of silicone 
in skin tissues and long-term complications of silicone use in cosmetic products must be evaluated for 
safety reasons. Silicone can penetrate to the skin by injection. Because of economic issues and the rarity 
of medical grade silicone, various developing countries use industrial silicone, which results in even 
more complications. Patients with liquid silicone injected to their nose will usually visit a doctor after 
experiencing complication issues such as granuloma, edema, redness with telangiectasia. Usually the 
patients want to remove the silicone and treat the complication. Unfortunately, silicone is difficult to be 
removed completely. Some complications are difficult to treat. To handle this complication issue, the 
doctor has to create a specific design of nose implant, performed curratage, or remove silicone and 
granuloma, and then a laser treatment and steroid injection will be performed.  
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Introduction  
Silicone injection has been used since 40 years ago, and at that time, many problems occurred 
such as migration, inflammation, and granuloma. In 1992, the FDA prohibited silicone injection for 
cosmetic use [1]. In addition to injection, silicone may be introduced into our body or skin through food 
intake and cosmetic. Silicone has been widely used in daily cosmetics. Nowadays, due to technology 
advances, topical drugs can pass through skin barrier and can be penetrated into the skin, which has 
become a great concern as it may induce granuloma formation. There are relatively very few studies 
that have been done on silicone concentration in the normal skin. 
A study conducted by Harlim in 2018 found that a normal skin contained silicon. The study was 
performed by taking skin samples from normal subjects and those with face-lift procedure and 
subsequently compared those samples using the same criteria with the control group, which included 
skin samples of subjects that had received silicone injection, and the study found granuloma formation. 
The study found an average amount of silicon level of 44.07 ± 75.86 μg/g in patients with normal skin, 
while in patients with granuloma, they found 38 times greater silicon level (1709.21 ± 1851.72 μg/g) [2]. 
 
Silicone  
Injectable-grade silicone for medical use has been manufactured widely since the element has 
been known for its stable and inert characteristics [3, 4]. It includes the use of silicone oil, which has 
been utilized in the treatment of complicated retinal detachment and heavy silicone oil tamponade. The 
treatment seems to offer promising results, particularly on improving visual acuity as well as great 
results on some anatomical parameters; however, there are some concerns as it may cause several 
complications such as cataract, increased ocular pressure, heavy silicone oil emulsification, and mild 
inflammatory reaction [5, 6, 7]. 
Injectable-grade silicone has also been widely used in the form of silicone oil injection. Some 
studies have suggested that it may have an essential role in reducing the risk of developing diabetic foot 
ulcer due to its pressure-reducing properties; therefore, it can maintain plantar tissue thickness and 
alleviate symptoms of diabetic foot ulcer, which may be associated with foot biomechanics [8, 9]. 
Although it brings advantages, silicone injection may still develop some complications, either 
local or systemic complications. Local complications may include formation of palpable nodule 
surrounding injection site, arthralgia, fatigue, electrical neuropathy, and electrical sensation [10], while 
systemic complications may also occur in the form of lymphadenopathy, renal disease, and hepatic 
disease. It indicates that the injected silicone can migrate from injection site to other organs causing 
local and systemic complications. An animal experimental study in mouse model may explain the 
pathogenesis of such complications. The study has demonstrated that macrophage of skin tissue may 
engulf the injected silicone and the silicone may be distributed through lymphatic circulation, 
ultimately causing accumulation in lymph nodes, adrenal glands, and the kidney, liver, and spleen as 
well as granuloma formation in the skin [11]. Complications due to silicone injection, particularly the 
granuloma formation may be dose-dependent. A study by Harlim has demonstrated that granuloma 
formation could be developed when there is a large amount of silicone exposure as the study only found 
a low level of silicone without any granuloma formation in the normal skin (Figure 1) [2]. 
 Cultural changes have been encouraging people to pursue their passion on beauty and youth; 
therefore, cosmeticology has been rapidly growing. With technological advances, more mixed drug 
ingredients have been added to cosmetic products in order to beautify their customers. Thus, it may 
indirectly increase the use of topical cosmetics that usually contain silicone; therefore, it will lead to 
increase silicone uptake to the skin. It has raised a concern that the prolonged and continuous use of 
cosmetics will cause granuloma formation and other chronic inflammatory effects. 
 
 
 
Figure 1. The level of silicon (Si) in normal subjects who had never received silicone injection (never 
injected) and in subjects with granuloma who had received silicone injection. (cited from A Harlim, et 
all) [2]. 
 
 
Dietary intake and silicon 
Aside from medical use, silicon has also been used in food industry, cosmetics, and 
pharmaceutical industries. Our data shows that the silicon levels in gastrointestinal medications (e.g., 
antacids), mineral water, and soda drinks are 44.1, 25.6, and 2.91 μg/g, respectively. It can be said that 
there are many routes for administering silicon into our body. The average daily intake of silicon for 
European and North American populations is 20–50 mg/day. In China and India, the daily intake of 
silicon is larger that may reach as many as 140–200 mg/day, in which wheats, fruits, and vegetables are 
the greatest producers [12]. 
A research institution of healthy aging and nutrition in the United Kingdom has recently 
reported a strong correlation between silicon in dietary intake and the health of bone and connective 
tissue. Therefore, it can be assumed that the correlation is associated with collagen synthesis and/or 
stabilization of mineral matrix, i.e., silicone intake may affect bone density [13]. 
Another study, which is an animal experimental study, has demonstrated that there is no 
evidence of silicon accumulation in silicon consumption. Silicon can be eliminated through digestion 
process and can be found in feces (93–97%), urine (0.001–0.22%), and expired air (0.01–0.02%) [3]. 
It indicates that silicon is a stable element and at certain degree it can be resistant to digestive enzymes 
including gastric acid; therefore, it seems that silicon is not accumulated in the gastroinstestinal system. 
Silicone in Cosmetics 
Beauty products for face, hair, and cosmetics may have high silicone content, in which it will be 
accumulated in the skin tissue. When a topical beauty product containing silicone is applied to the skin, 
the elastomeric particles of silicone will absorb various liquids including emollient and oil; therefore, 
silicone is used in skin care product as vehicle (carrier) of active ingredient for the skin or as oil control 
product of the skin [4, 5]. 
Types of silicone that are commonly used in cosmetic products: • Dimethicone—clear, inert, liquid solubility depends on the length of polymer backbone ranging 
in thickness from watery consistency to thick. 
• Dimethicone copolyol—silicone that contains an —OH group; therefore, it is more water-
soluble resulting in easier incorporation into water-based formulations and also reduces the 
“slip effect” of the silicone. 
• Cyclomethicone—the shortest cyclic molecule, which has many similarities with dimethicone 
except it can evaporate, while dimethicone cannot. 
• Cyclo-dimethicone—a combination of dimethicone and cyclomethicones. 
The great use of silicones in cosmetic product may increase the risk of accumulation of the 
substance in our body, particularly in the facial skin. No clear evidence has been found on the 
bioavailability and concentration of accumulated silicone in topical uses. 
 
Granuloma: Definition  
Granuloma is a foreign body reaction against foreign substances that enter the skin. Granuloma 
occurs due to continuous or chronic inflammation against foreign substances. Silicone is a foreign 
substance in the body, which will be encapsulated by the body. Datia cells (giant cells) will encapsulate 
silicone material, and therefore inflammatory mediators cannot perform phagocytosis, which results in 
continuous inflammation and causes side effect. The encapsulated material has poor vascularization; 
therefore, it may potentially induce infections [6]. 
  
Classification and etiology  
There are many kinds of granuloma classification; however, the common classifications are 
those which have been adjusted to the etiologies [7, 8]. Granuloma formation may occur due to various 
factors such as biologic, chemical, and physical irritative agents [7]. Classification based on clinical, 
etiological, and histopathological features can be categorized further into infection, vasculitis, 
immunological aberration, leukocyte oxidation deficiency, hypersensitivity, chemicals, or neoplasma 
[14, 15]. Table 1 presents classification of granuloma based on etiology [8]. 
 
========================================================= 
Infections    Immunological aberrasion  
========================================================= 
Fungi     Sarcoidosis 
Histoplasma    Crohn’s disease 
Coccidioides    Phimary billiary cirrhoris 
Blastomyces    Giant cell arteritis 
Sporothrix    Peyronie’s disease 
Aspergillus    Hypogammaglobulinaemia 
Cryptococcus    Langerhans’ granulomatosis 
     Hepatic granulomatous disease 
Immune complex disease 
Protozoa         
Interferon-δ-receptor deficiency  
Toxoplasma 
Leishmania 
     Vasculitic granulomatosis 
Metazoa    Wegener’s 
Toxocara    Necrotizing sarcoidal 
Schistosoma    Churg-Strauss 
     Lymphomatoid 
Sprirochaetes   Polyarteritis nodosa 
T.Pailidum    Bronchocentric 
T.carateum    Systemic lupus 
T.pertune    
 
      
Mycobacteria    Leukocyte cocidase defect 
M. tuberculosis    Chronic granulomatous 
M. leprae     disease of childhood 
M. kansasii     
M. marinum    Hypersensitivity pneumonitis 
M. avian    Farmers’ lung 
BCG vaccine    Bird fanciers’ 
     Mushroom workers’ 
Bacteria    Suberosis (cork dust) 
Brucella    Bagassosis 
Yersinia    Marple bark strippers’ 
     Paprika splitters’ 
Other infections    Coffee bean 
Cat-scratch    Spatlese lung 
Lymphogranuloma       
     Other 
Neoplasia    Fibrosing alveolitis 
Carcinoma    Whipple’s disease 
Reticulosis    Pyrexia of unknown origin 
Pinealoma    Radiotherapy 
Dysgerminoma    Cancer chemotherapy 
Seminoma    Panniculitis 
Reticulum cell sarcoma   Chalazion 
Malignant nasal granuloma  Sebacous cyst 
     Dermoid 
Chemicals    Sea urchin spine injury 
Beryllium    Tattoo 
Zirconium    Malakoplakia 
Silica     Blau’s syndrome 
Starch  
Table 1. Classification of granulomatous disorders (cited from James DG, Wiliams WL) [8]. 
 
Silicone granuloma  
Silicone granuloma is a foreign body granuloma, which is characterized by the presence of 
multinuclear Datia cells and macrophages surrounded by lymphocytes and infiltrates of neutrophils. 
The granulomatous histological lesion caused by silicone varies depending on the type of silicone. 
Tissue reactions to silicone gel or liquids are characterized by the formation of silicone 
granuloma with cystic space containing foreign body [9]. The irregular surface of silicone cannot be 
phagocytosed completely by macrophage. Datia cells are formed due to “frustrated” macrophages. 
Microspheres in the size of less than 15 microns will be phagocytosed and transferred to the lymph node, 
while those with big size and nonabsorbable polymer will be encapsulated by fibrotic tissue [10]. 
 
       
Figure 2. Results of histopathological examination (HE 400× magnification) in one of study subject. 
There is a Datia cell (arrow), which is phagocytosing silicone (S) and is trying to destroy it into smaller 
pieces (sk) [1]. 
 
Datia cell is essential in tissue response to silicone as seen in Figure 2, in which the Datia cell is 
phagocytosing the silicone. It appears that although the Datia cell cannot eliminate the silicone, it would 
produce fragmented silicone into smaller pieces. Within a month, the silicone will be in the size of 20–
100 microns [11]. However, it still cannot be completely phagocytosed, and ultimately it will be 
encapsulated by fibrotic tissue. 
In general, silicone granuloma can be categorized into three phases according to the natural 
history of our immune response, which are mild inflammatory phase, i.e., stage 1; inflammation with 
datia cells, i.e., stages 2, 3, 4, and 5; and tolerance phase with fibrosis, i.e., stages 6 and 7 (Figure 3). 
 
According to Harlim in 2018, histopathological features of silicone granuloma can be categorized into 
seven stages, which are: [11] 
Stadium 1, moderate reaction with a few inflammatory cells 
Stadium 2, inflammatory cells with one or two Datia cells 
Stadium 3, inflammatory cells with more than two Datia cells and <50% fibrotic area 
Stadium 4, inflammatory cells with more than two Datia cells and >50% fibrotic area 
sk 
sk 
sk 
S 
S 
S 
 
Stadium 5, inflammatory cells with one Datia cell and >50% fibrotic area 
Stadium 6, <50% fibrotic area with no Datia cell 
Stadium 7, >50% fibrotic area with no Datia cell 
 
Stadium 1           Stadium 2 
 
Stadium 3 
 
Stadium 4    
 
Stadium 5 
 
 
 Stadium 6         Stadium 7 
Figure 3. Stadium 1, moderate reaction with a few inflammatory cells. Stadium 2, inflammatory cells 
with one or two Datia cells. Stadium 3, inflammatory cells with more than two Datia cells and <50% 
fibrotic area. Stadium 4, inflammatory cells with more than two Datia cells and >50% fibrotic area. 
Stadium 5, inflammatory cells with one Datia cell and >50% fibrotic area. Stadium 6, <50% fibrotic area 
with no Datia cell. Stadium 7, >50% fibrotic area with no Datia cell. (cited from A Harlim, et all) [11]. 
 
Diagnosis  
Granuloma is a form of localized nodular inflammation, which is found in tissues [7]. On 
examination, there is a tumor-like mass or node of granulation tissue with active fibroblast growth and 
capillaries that contain epithelial-like macrophages surrounded by mononuclear cells, lymphocytes, 
and sometime multinucleated Datia cells present at the central core of granuloma [16]. 
On clinical point of view, silicone granuloma is characterized by the presence of complications 
of silicone. There are usually granuloma nodes, migrating silicone, wider nose, and signs of 
inflammation such as redness and swelling depending on the stage (Figure 4). 
 
 
Figure 4. Granuloma due to nasal silicone injection. The photograph shows granuloma node, 
migrating silicone, wider nose, and signs of inflammation such as edema and redness. 
 
Management  
The management of silicone-induced granuloma is often difficult due to migrating silicone and 
some of the silicone penetrating into the skin reaching the epidermis. In general, the management of 
granuloma can be categorized into two, i.e., surgical and pharmacological treatments. The management 
of nasal silicone granuloma is adjusted for the occurring complications. We must remove granuloma, 
which is under the skin; afterward, we perform excision of the excessive skin or implant insertion, 
creating a firmer and cosmetically more attractive skin. Remaining fibrosis or granuloma can be treated 
using steroid injection, and laser therapy is performed for redness. 
 
Recommendation for surgical care  
Granuloma formation occurs due to the presence of foreign body. Skin granuloma will cause a 
cosmetic problem; therefore, it should be removed. 
 
Preoperative preparation 
The preoperative preparation is similar to all kinds of skin surgery. A consultation prior to 
surgical procedure is necessary so that the doctor can perform both physical and psychological 
evaluation for the candidate. The patient should be informed about surgical procedure and the result 
may not be perfect as clean silicone injection can never be performed and there is a possibility of 
swelling. Patients with extreme high expectation will file their complaints in the future. 
During the consultation, we must find out about coagulation disorder, either primary or 
secondary, either due to medication of pharmacological treatment or supplementation. The patients are 
advised to avoid food or medication that may prolong the bleeding time within 1 or 2 weeks prior to the 
procedure such as anticoagulants, aspirin, ginseng, garlic, cod liver oil, anticholesterol agent, vitamin 
E, warfarin, and Ginkgo biloba. 
Curettage procedure of nasal silicone granuloma is similar to skin graft procedure, in which the 
covering skin must be viable. On curettage, the skin will be thinner, and it can be necrotic if there is 
poor vascularization. Other issues that should come into our consideration are alcohol intake, smoking 
habit, metabolic disorder, and poor nutrition. Blood pressure and diabetes mellitus must be well-
controlled [17, 18, 19]. 
 
Informed consent  
 When a skin surgeon decides to perform a surgical procedure, both doctor and patient must 
consequently understand the impact, risk, and advantages of the procedure. First, the doctor needs to 
explain the diagnosis and the procedure that will be performed. Treatment of nasal silicone injection is 
a combination of medical therapy and cosmetic procedure because when it is left untreated, there will 
be changes such as migration, granuloma, and continuous inflammation. The risks and the advantages 
of the procedure should be emphasized. Moreover, the procedure during the surgery and the expected 
result after surgery need to be explained. Possible risks that may develop such as infection and its 
prevention including the use of antibiotics must also be explained. Patients must know other probable 
risks such as bleeding, crooked nose, wound scar that probably occurs, asymmetrical nostrils, an 
implant impression on the skin, granuloma or fibrosis that cannot be cleaned up, persistent redness of 
skin color, and other modalities of treatment that need to be carried out after the surgical procedure. It 
should also be explained that the results probably may be imperfect, particularly for patients with 
unrealistic wish. Results of discussion and patient’s consent are written on an informed consent form, 
which is subsequently signed by the doctor and patient. 
 
Technique and procedure   
Every granuloma in the skin that causes cosmetic problem must be removed. Granuloma at 
inflammatory phase must also be removed to prevent the extension of inflammation. Local or general 
anesthesia could be used for procedures of skin excision, granuloma curettage, or installation of nasal 
implant. Instruments that must be prepared included minor surgery set, which can be equipped with 
curettage kit for cases that need curettage. 
 
Preoperative Planning 
The management of silicone-induced granuloma depends on the affected area; however, 
basically a doctor will first make a design planning. Next, the doctor will perform procedures according 
to the design or images and following the plan that has been discussed with the patient. 
Depending on the occurring complication, we evaluate whether we need to remove the 
excessive skin from the nasal columella or should only perform curettage and subsequently install a 
nasal implant. 
Mark the area that will be excised and the protruding granuloma on the dorsal of the nose; 
therefore, during the surgery we emphasize on the location where the curettage will take place. If we 
plan to place a solid nasal implant, then we need to make a midline to ensure the implant stays straight 
when the swelling occurs due to anesthetic drugs. 
Depending on the problem, when the nasal dorsum has become wider along with inflammation 
and the damaged skin, an elliptical vertical excision can be performed on it (Figure 5). 
 
 
Figure 5. Elliptical excision of granuloma on the nasal skin. 
 
During silicone injection, it is common to have a wider and descending skin at the area of nasal 
columella due to migration of silicone injection, which always run downward from the nose; therefore, 
a skin excision can be performed at lateral and dorsal areas of the nasal columella (Figure 6). 
 
Figure 6. Design of excision procedure to remove the excessive skin at columella area. 
 
Technique 
After we have planned the management to overcome nasal problems, we subsequently transfer 
the plan into preoperative design images and subsequently perform an incision or excision following 
the plan. 
 
Design of nasal implant   
In some cases that require implants, the nasal implant is first carved before an excision is 
performed. Solid implant that has been commonly used is the L-shaped solid implant; however, other 
kinds of solid implant can also be used. 
In making an implant, there are some guidelines on facial esthetics and architectural balance 
that should be considered. 
The face can be divided into three zones with identical width. The first includes a horizontal 
line from the hairline to the eyebrow; the second horizontal line is from the eyebrow to the nasal base 
and menton; and the third horizontal line is the line from the nasal base to the end border of the chin. 
The association between the lips and chin should be evaluated. The chin projection is 
determined by a vertical line drawn from a point of one and a half ideal length of the nose to the part of 
vermillion of the upper lip. The lower lip cannot be more than 2 mm posterior to this line. The position 
of chin varies extremely depending on sex. In women, the position is slightly posterior to the lower lips, 
while in men the position of the chin is in-line[20, 21]. 
 
The implant is carved or made prior to anesthetic procedure following the guidelines of 
architectural balance and problems of nasal silicone granuloma as well as the patient’s preferences. For 
nasal silicone granuloma cases, L-shaped nasal solid implant is used, and part of the nasal bridge is 
shaved so that it becomes slender since patients with granuloma due to silicone injection usually have 
wider nose and they want the nose become slender (Figure 3). 
The height or the length of the implant is the midline border between the eye and eyebrow up 
to the nose. The crus of the implant must be measured following the base of columella to the nose. 
Usually, the crus is made straight so that it can elevate the descending skin caused by silicone injection 
( 
Figure  9. Patients with silicone injection usually have wider columella area since liquid silicone will 
migrate downward due to gravity. Therefore, we have to remove the excessive skin of the lateral and the 
dorsal columella and place the implant to create a straight nose. 
 
Incision is always made on a hidden area and follows the contour of Langer’s line. The excision 
is made following preoperative design image, which is an elliptical excision on the nasal dorsum (Figure 
5); the procedure is generally performed when the condition is very severe with inflammation and the 
skin is wrinkled and extremely wider. The risks of the procedure are the formation of thin vertical scar 
line on the nasal dorsum and dog-ear phenomenon at the end of excision. An accurate calculation before 
surgery is essential. It is suggested that the skin removal should not be too wide to prevent dog-ear 
phenomenon or we can place a nasal implant so that it seems firm and creates a better look. Excision 
can also be made on the area adjacent to excision cut in order to reduce granuloma around the lateral 
nose. The skin superior to the granuloma must be thick enough to maintain vascularization and a viable 
skin. Many patients do not want any lengthy scar along their nose; therefore, the management of nasal 
silicone granuloma only includes curettage, placement of implant, and excision of the excessive skin at 
columella area. 
After the patient received anesthetics using lidocaine or xylocaine without adrenalin, we 
perform a skin excision at the columella area and remove the excessive skin on the lateral and dorsal 
columella; afterwards, we perfom undermining procedure inferior to the granuloma using a curved 
clamp starting from the nasal dorsum area to the nasal bridge near the glabella and lateral of nose 
depending on the occurring problem. Next, curettage is performed to remove the granuloma. The skin 
superior to it must be thick enough and well-vascularized. In cases with remaining granuloma with thick 
fibrosis and those with difficulty in curettage, other modalities should be performed after surgical 
recovery period such as steroid injection. 
To create a good-shaped nose, we remove the excessive skin at the columella area, and at the 
nasal bridge, we can place an implant so that the skin is firmer and the shape is cosmetically better. 
Nasal silicone implant is placed under the nasal skin at the curettage area, which has been previously 
occupied by silicone granuloma. 
We can perform curettage to remove silicone and granuloma. In order to create a better 
superior nasal tip so that the nose seems straighter, we have two choices. The first choice is that we can 
place the implant under the skin, and at the area, the curettage is performed; or we can put sutures at 
the lateral area of superior tip of the nose from lateral columella with opposite direction as presented 
in the following video. 
 
Postoperative Management  1. Use nasal splint or gauze for a week to prevent splint displacement. 
2. Prescribing antibiotics for 5–7 days. 
3. Prescribing analgetics every 4–6 hours as necessary. 
4. Prescribing anti-inflammatory drugs for 5–7 days. 
5. Normal saline solution for the nose to overcome postsurgical nasal congestion. 
6. To reduce swelling, apply cold compress to periorbital within the first 48 hours. 
7. When sleeping, the patient should keep the head elevated approximately 45°. 
8. If there is a seroma, we can remove it by suctioning using syringe during the follow-up visit. 
9. Avoid any trauma for 2 weeks. 
10. Remove the stitches on day 10–14. 
11. Have a normal diet, but avoid foods that cause excess lip movement such as apples and corn on 
the cob for 2 weeks after surgery (Figure 10). 
 
 
 
 
 
 
 
      (a)                                               (b) 
Figure 7. Patients with silicone injection usually have wider columella area (a). After the excessive skin 
of the lateral and the dorsal columella are removed and the implant is placed, the columella area will be 
more slender, thus shaping a straighter nose (b). 
 
 
Adjunctive Therapy to Overcome Other Complications 
The principle of therapy in managing patients with granuloma due to silicone injection is 
preventing the development of inflammation as it will cause extention of damage. 
Evacuation of silicone-induced granuloma should be performed since the liquid silicone in the 
tissue is persistent and will continuously induce immune response. Although the granuloma has been 
excised, the remaining silicone, which has migrated to all direction and has been absorbed in the skin, 
cannot be removed, and therefore, it may cause recurrent granuloma. The remaining inflammation, 
both granuloma and fibrosis, requires further treatment. 
For granuloma or fibrosis that cannot be removed by surgical procedure, other modalities are 
required to treat the remaining fibrosis and inflammation that can still be seen on the skin, i.e., skin 
redness and telangiectasia. 
 
Fibrosis and remaining granuloma  
Some case reports suggest that to treat silicone-induced granuloma, intralesion injection can 
be used as well as topical treatment of pimecrolimus, which is applied two times daily for 3 months. 
Topical imiquimod can be used for 8 weeks as well as minoxillin, allopurinol, and oral prednisone at 
the dose of 30 mg/day [22, 23]. Results of those treatment have not been satisfying although intralesion 
injection of triamsinolone is more significant for treating the occurring inflammation [24]. 
Granuloma and remaining fibrosis may also be treated with subdermal injection of 
triamcinolone acetonide at a dose of 10 mg/ml or a combination of triamcinolone acetonide and 5-
fluorouracil. Steroid injection can be performed at the earliest within 2 weeks after wound closure. 
The injection is performed once or twice weekly as many as five to seven times. The dose 
depends on the amount of remaining granuloma and fibrosis, and usually it is at dose of 0.2–0.4 cc per 
injection. 
Etanercept, which works on TNF-α receptor and Fc-IgG1 binding, has been reported providing 
good result for silicone granuloma [25, 26, 27]. The administration of this drug at the dose of 50 mg 
twice weekly or 25 mg of subcutaneous injection two times a week has offered relatively satisfying 
results [27]. 
 
Redness on Nasal Skin  
When the silicone has entered into the skin, it can cause granuloma due to chronic 
inflammation. Although the granuloma has been removed, the remaining inflammation, e.g., redness 
on skin, still exists. One of them is redness due to neovascularization such as telangiectasia due to 
silicone block in the skin. 
Nasal redness and telangiectasia can be reduced using laser treatment. To utilize laser for 
treatment, we need basic knowledge about the use of laser. 
There are three characteristic properties of laser light: monochromatic light. The light contains 
only a single wavelength, which is determined by the magnitude of released energy. The light has 
coherent characteristic, and the photon moves regularly as it has the same wavefront to one another. 
The light is highly directional. A laser light has a very tight beam that is dense, strong, and 
concentrated. The three abovementioned characteristics can be achieved since there is a process of 
stimulated emission. 
A light is part of the spectrum of electromagnetic radiation with an energy known as photon, 
while the molecule that absorbs the light is called chromophore. The energy is transferred from photon 
entering into chromophore in the skin. After the energy is absorbed, the light can initiate photochemical 
reaction, heat up the tissue to the state of coagulation or evaporation, and can destroy or detonate tissue 
structure through extremely rapid localized heating. 
Laser is an instrument that produces light beam with certain wavelength or color that is very 
parallel and coherent. The light wavelength is absorbed maximally by the component of the treated skin. 
When the absorption characteristics of the target tissue accurately meet the most ideal wavelength, it 
will develop maximum specificity of laser to tissue interaction. 
The mechanism of action of laser is consistent with specific chromophore with certain 
wavelength. There are three major chromophores in the body, which are hemoglobin, pigment, and 
water. For redness and telangiectasia cases, we use laser, which mostly works on hemoglobin. The 
wavelength of laser must be adjusted to the existing problem. Laser light enters the target area on the 
skin, and subsequently the light is absorbed by specific blood vessel in the skin causing damage on the 
target blood vessel that contains hemoglobin without injuring the surrounding tissue. We need basic 
knowledge to perform safer use of laser [28, 29]. 
In addition to chromophore, we also need to know about thermal relaxation time (TRT). TRT 
is the time it takes for a target substance to cool half the temperature needed for heating the target 
without increasing the temperature of surrounding tissue. In order to perform safe procedure, the 
fluence of a laser pulse must be high enough to heat the target, and the pulse duration must be shorter 
than the TRT of the target. Each target has its own TRT. For blood vessel, which has TRT up to 
microseconds, we need long pulse duration; therefore, we should use the long-pulse Nd:Yag laser 
instead of the QS Nd:Yag laser, which only has pulse duration of nanoseconds. QS Nd:Yag is usually 
used for tattoo removal. 
Laser works based on the selective photothermolysis principle. In this case, it can be used for 
hemoglobin to treat redness due to the silicone injection. Some lasers that can also be used are vascular 
laser such as pulse dye laser (PDL) or long-pulse Nd:Yag [30, 31]. 
A previous study shows that pulse dye laser (PDL) with a wavelength of 595 nm can be used for 
vascular disorder such as angioma, port-wine stain, rosacea, or other vascular disorders at the dose of 
6–8 J/cm2 every 8 weeks. To prevent side effect, cooling is always performed before laser procedure; 
some instruments have already had a cryo cooler. The side effects of post-PDL laser treatment are 
bruising, crust, post-inflammatory hyperpigmentation, particularly for skin types 3–6 according to 
Fitzpatrick classification [30]. 
Long-pulse Nd:Yag laser with a wavelength of 1064 nm is also good for treatment of vascular 
disorder. For deeper vascular disorders and those abnormalities in patients with dark skin types such 
as the Fitzpatrick skin types 3–6, the instrument will give greater advantages because the 1064 nm 
wavelength is usually used for pigment chromophore. In contrast, the instrument also has lower safety 
limit as poor cooling process can often burn the skin. Side effects of long-pulse Nd:Yag laser are bullae, 
crust, post-inflammatory hyperpigmenta-tion, and scar [31, 32]. 
In utilizing the long-pulse Nd:Yag laser, we need to set the pulse duration. In silicone-induced 
disorders, there will be redness on the skin, and one of them is telangiectasia that requires higher dose 
but lower pulse duration  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a)        (b) 
Figure 8. Illustration of a patient’s skin due to complication of silicone injection on the nasal skin; 
there is an erythematous skin, and among them, there is a telangiectasia (a). After Nd:Yag laser, the 
reddish skin and telangiectasia are reduced (b). 
 
In erythematous skin cases, the long-pulse Nd:Yag laser with a wavelength of 1064 nm, at dose 
of approximately 100 J, spot size of 4, and pulse duration of 10 ms, can be used. For telangiectasia, the 
power is approximately of 180 J, a spot size of 2, and pulse duration of 5 ms. Sufficient cooling before 
and after laser procedure should be done, either by using ice pack, air cooling, cryo, or other methods. 
The laser treatment should be started at a low dose, and the dose is increased gradually for each visit 
until a change can be observed. The target does not diminish instantly; the color does not always change 
rapidly; sometimes it only becomes paler. 
 
Pitfalls and the Management  
For a necrotic skin, skin excision on the nasal dorsum is usually done, which is followed by 
curettage of the surrounding area. We usually clean up the necrotic area and performed wound care, 
open wound healing enhanced with topical medication that can induce granulation, laser diode, PRP, 
or others. In general, the wound will heal in 2–3 months. 
Excessive granuloma or extensive fibrotic area occurs due to a hard necrotic skin, which creates 
difficulty in curettage. We can repeat the curettage procedure after a few months, which is followed by 
steroid injection. For less good-looking nose, excision procedure of the remaining skin can be repeated. 
The skin can be burnt due to laser treatment for removing redness or telangiectasia for nasal 
area. Sufficient cooling before and after laser procedure should be done immediately. Sometime a 
strong topical steroid such as clobetasol propionate can be applied directly onto the skin after the laser 
procedure. 
 
Conclusion  
Treatment for silicone-induced granuloma is not easy because the silicone that enters the skin 
can migrate and a lot of modalities are required to treat complications. Although the use of silicone 
injection has been prohibited, we still need to be cautious because there are many cosmetics containing 
silicone, especially with technological advances that can make the silicone readily absorbed by the skin. 
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